Congress Passes Steroid Control Act
Anabolic Steroid Control Act of 2004
(Enrolled as Agreed to or Passed by Both House and Senate)
One Hundred Eighth Congress of the United States of America
AT THE SECOND SESSION
Begun and held at the City of Washington on Tuesday, the twentieth day of January, two thousand and four
To amend the Controlled Substances Act to clarify the definition of
anabolic steroids and to provide for research and education activities
relating to steroids and steroid precursors.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the `Anabolic Steroid Control Act of 2004'.
SECTION 2. AMENDMENTS TO THE CONTROLLED
(a) DEFINITIONS- Section 102 of the Controlled Substances Act (21 U.S.C.
802) is amended--
(1) in paragraph (41)--
(A) by realigning the margin so as to align with paragraph (40); and
(B) by striking subparagraph (A) and inserting the following:
(A) The term `anabolic steroid' means any drug or hormonal substance,
chemically and pharmacologically related to testosterone (other than
estrogens, progestins, corticosteroids, and dehydroepiandrosterone), and
(II) 4-androstenedione (androst-4-en-3,17-dione);
(v) bolasterone (7a,17a-dimethyl-17b-hydroxyandrost-4-en-3-one);
(vi) boldenone (17b-hydroxyandrost-1,4,-diene-3-one);
(vii) calusterone (7b,17a-dimethyl-17b-hydroxyandrost-4-en-3-one);
(viii) clostebol (4-chloro-17b-hydroxyandrost-4-en-3-one);
(x) *1-dihydrotestosterone (a.k.a. `1-testosterone')
(xi) 4-dihydrotestosterone (17b-hydroxy-androstan-3-one);
(xii) drostanolone (17b-hydroxy-2a-methyl-5a-androstan-3-one);
(xiii) ethylestrenol (17a-ethyl-17b-hydroxyestr-4-ene);
(xvi) furazabol (17a-methyl-17b-hydroxyandrostano[2,3-c]-furazan);
(xviii) 4-hydroxytestosterone (4,17b-dihydroxy-androst-4-en-3-one);
(xix) 4-hydroxy-19-nortestosterone (4,17b-dihydroxy-estr-4-en-3-one);
(xx) mestanolone (17a-methyl-17b-hydroxy-5a-androstan-3-one);
(xxi) mesterolone (1a-methyl-17b-hydroxy-[5a]-androstan-3-one);
(xxii) methandienone (17a-methyl-17b-hydroxyandrost-1,4-dien-3-one);
(xxiii) methandriol (17a-methyl-3b,17b-dihydroxyandrost-5-ene);
(xxiv) methenolone (1-methyl-17b-hydroxy-5a-androst-1-en-3-one);
(xxv) 17a-methyl-3b, 17b-dihydroxy-5a-androstane;
(xxix) methyldienolone (17a-methyl-17b-hydroxyestra-4,9(10)-dien-3-one);
(xxx) methyltrienolone (17a-methyl-17b-hydroxyestra-4,9-11-trien-3-one);
(xxxi) methyltestosterone (17a-methyl-17b-hydroxyandrost-4-en-3-one);
(xxxii) mibolerone (7a,17a-dimethyl-17b-hydroxyestr-4-en-3-one);
(xxxiv) nandrolone (17b-hydroxyestr-4-en-3-one);
(I) 19-nor-4-androstenediol (3b,
(II) 19-nor-4-androstenediol (3a,
(III) 19-nor-5-androstenediol (3b,
(IV) 19-nor-5-androstenediol (3a,
(xxxvii) norbolethone (13b,17a-diethyl-17b-hydroxygon-4-en-3-one);
(xxxviii) norclostebol (4-chloro-17b-hydroxyestr-4-en-3-one);
(xxxix) norethandrolone (17a-ethyl-17b-hydroxyestr-4-en-3-one);
(xl) normethandrolone (17a-methyl-17b-hydroxyestr-4-en-3-one);
(xli) oxandrolone (17a-methyl-17b-hydroxy-2-oxa-[5a]-androstan-3-one);
(xlii) oxymesterone (17a-methyl-4,17b-dihydroxyandrost-4-en-3-one);
(xliv) stanozolol (17a-methyl-17a-hydroxy-[5a]-androst-2-eno[3,2-c]-pyrazole);
(xlv) stenbolone (17b-hydroxy-2-methyl-[5a]-androst-1-en-3-one);
(xlvi) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic
(xlvii) testosterone (17b-hydroxyandrost-4-en-3-one);
(xlix) trenbolone (17b-hydroxyestr-4,9,11-trien-3-one); and
(xlx) any salt, ester, or ether of a drug or substance described in this
The substances excluded under this subparagraph may at any time be scheduled
by the Attorney General in accordance with the authority and requirements of
subsections (a) through (c) of section 201.'; and
(2) in paragraph (44), by inserting `anabolic steroids,' after `marihuana,'.
(b) AUTHORITY AND CRITERIA FOR CLASSIFICATION- Section 201(g) of the
Controlled Substances Act (21 U.S.C. 811(g)) is amended--
(1) in paragraph (1), by striking `substance from a schedule if such
substance' and inserting `drug which contains a controlled substance from
the application of titles II and III of the Comprehensive Drug Abuse
Prevention and Control Act (21 U.S.C. 802 et seq.) if such drug'; and
(2) in paragraph (3), by adding at the end the following:
`(C) Upon the recommendation of the Secretary of Health and Human Services,
a compound, mixture, or preparation which contains any anabolic steroid,
which is intended for administration to a human being or an animal, and
which, because of its concentration, preparation, formulation or delivery
system, does not present any significant potential for abuse.'.
(c) ANABOLIC STEROIDS CONTROL ACT- Section 1903 of the Anabolic Steroids
Control Act of 1990 (Public Law 101-647) is amended--
(1) by striking subsection (a); and
(2) by redesignating subsections (b) and (c) as subsections (a) and (b),
(d) EFFECTIVE DATE- The amendments made by this section shall take effect 90
days after the date of enactment of this Act.
SECTION 3. SENTENCING COMMISSION GUIDELINES.
The United States Sentencing Commission shall--
(1) review the Federal sentencing guidelines with respect to offenses
involving anabolic steroids;
(2) consider amending the Federal sentencing guidelines to provide for
increased penalties with respect to offenses involving anabolic steroids in
a manner that reflects the seriousness of such offenses and the need to
deter anabolic steroid trafficking and use; and
(3) take such other action that the Commission considers necessary to carry
out this section.
SECTION 4. PREVENTION AND EDUCATION PROGRAMS.
(a) IN GENERAL- The Secretary of Health and Human Services (referred to in
this Act as the `Secretary') shall award grants to public and nonprofit
private entities to enable such entities to carry out science-based
education programs in elementary and secondary schools to highlight the
harmful effects of anabolic steroids.
(1) APPLICATION- To be eligible
for grants under subsection (a), an entity shall prepare and
submit to the Secretary an application at such time, in such manner, and
containing such information as the Secretary may require.
(2) PREFERENCE- In awarding grants
under subsection (a), the Secretary shall give preference to applicants that
intend to use grant funds to carry out programs based on--
(A) the Athletes Training and Learning to Avoid Steroids program;
(B) The Athletes Targeting Healthy Exercise and Nutrition Alternatives
(C) other programs determined to be effective by the National Institute on
(c) USE OF FUNDS- Amounts received under a grant under subsection (a) shall
be used for education programs that will directly communicate with teachers,
principals, coaches, as well as elementary and secondary school children
concerning the harmful effects of anabolic steroids.
(d) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated
to carry out this section, $15,000,000 for each of fiscal years 2005 through
SEC. 5. NATIONAL SURVEY ON DRUG USE AND HEALTH.
(a) IN GENERAL- The Secretary of Health and Human Services shall ensure that
the National Survey on Drug Use and Health includes questions concerning the
use of anabolic steroids.
(b) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated
to carry out this section, $1,000,000 for each of fiscal years 2005 through
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.
View more information on this act.